Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial.

He M, Li Q, Zou R, Shen J, Fang W, Tan G, Zhou Y, Wu X, Xu L, Wei W, Le Y, Zhou Z, Zhao M, Guo Y, Guo R, Chen M, Shi M.

JAMA Oncol. 2019 May 9. doi: 10.1001/jamaoncol.2019.0250. [Epub ahead of print]

PMID:
31070690
2.

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread.

Lyu N, Kong Y, Pan T, Mu L, Li S, Liu Y, Deng H, Li J, Shi M, Xu L, Guo R, Chen M, Wu P, Zhao M.

J Vasc Interv Radiol. 2019 Mar;30(3):349-357.e2. doi: 10.1016/j.jvir.2018.09.004.

PMID:
30819477
3.

Association of Sustained Response Duration With Survival After Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma.

Zhang Y, Zhang M, Chen M, Mei J, Xu L, Guo R, Lin X, Li J, Peng Z.

JAMA Netw Open. 2018 Oct 5;1(6):e183213. doi: 10.1001/jamanetworkopen.2018.3213.

4.

High molecular weight hyaluronic acid regulates P. gingivalis-induced inflammation and migration in human gingival fibroblasts via MAPK and NF-κB signaling pathway.

Chen M, Li L, Wang Z, Li P, Feng F, Zheng X.

Arch Oral Biol. 2019 Feb;98:75-80. doi: 10.1016/j.archoralbio.2018.10.027. Epub 2018 Nov 1.

PMID:
30465936
5.

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation.

Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhang Y, Chen M.

Cancers (Basel). 2018 Oct 10;10(10). pii: E378. doi: 10.3390/cancers10100378.

6.

A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma.

Chen J, Fang A, Chen M, Tuoheti Y, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhu H, Zhang Y.

Cancer Med. 2018 Oct;7(10):5027-5035. doi: 10.1002/cam4.1787. Epub 2018 Sep 27.

7.

High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis.

Shakya M, Zhou A, Dai D, Zhong Q, Zhou Z, Zhang Y, Li X, Bholee AK, Chen M.

Cancer Biomark. 2018;22(4):611-619. doi: 10.3233/CBM-170091.

8.

Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis.

Chen J, Lu S, Zhang Y, Xu L, Chen J, Wang J, Chen M, Zhang R, Zhou Z.

J Cancer. 2018 Apr 19;9(10):1745-1753. doi: 10.7150/jca.24568. eCollection 2018.

9.

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.

Zhang Y, Huang J, Chen J, Yang K, Chen J, Xu L, Zhou Z, Chen M.

Cancer Manag Res. 2018 Mar 27;10:599-611. doi: 10.2147/CMAR.S160047. eCollection 2018.

10.

42,573 cases of hepatectomy in China: a multicenter retrospective investigation.

Zhang B, Zhang B, Zhang Z, Huang Z, Chen Y, Chen M, Bie P, Peng B, Wu L, Wang Z, Li B, Fan J, Qin L, Chen P, Liu J, Tang Z, Niu J, Yin X, Li D, He S, Jiang B, Mao Y, Zhou W, Chen X.

Sci China Life Sci. 2018 Jun;61(6):660-670. doi: 10.1007/s11427-017-9259-9. Epub 2018 Feb 2.

PMID:
29417360
11.

Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.

Peng Z, Chen S, Wei M, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Chen M, Qian G, Kuang M.

Radiology. 2018 May;287(2):705-714. doi: 10.1148/radiol.2018171541. Epub 2018 Feb 1.

PMID:
29390197
12.

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma.

Zhang Y, Xi S, Chen J, Zhou D, Gao H, Zhou Z, Xu L, Chen M.

J Cancer. 2017 Aug 25;8(15):2992-3000. doi: 10.7150/jca.21038. eCollection 2017.

13.

Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients.

Chen J, Huang J, Chen M, Yang K, Chen J, Wang J, Xu L, Zhou Z, Zhang Y.

J Cancer. 2017 Aug 25;8(15):2984-2991. doi: 10.7150/jca.20978. eCollection 2017.

14.

Association between the functional polymorphism Ile31Phe in the AURKA gene and susceptibility of hepatocellular carcinoma in chronic hepatitis B virus carriers.

Bao Z, Lu L, Liu X, Guo B, Zhai Y, Li Y, Wang Y, Xie B, Ren Q, Cao P, Han Y, Jia W, Chen M, Liang X, Wang X, Zeng YX, He F, Zhang H, Cui Y, Zhou G.

Oncotarget. 2017 Jun 27;8(33):54904-54912. doi: 10.18632/oncotarget.18613. eCollection 2017 Aug 15.

15.

Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment.

Wang J, Mao Y, Liu Y, Chen Z, Chen M, Lao X, Li S.

J Gastrointest Surg. 2017 Jul;21(7):1128-1135. doi: 10.1007/s11605-017-3420-3. Epub 2017 Apr 10.

16.

Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.

Cheng S, Chen M, Cai J; National Research Cooperative Group for Diagnosis and Treatment of Hepatocellular Carcinoma with Tumor Thrombus.

Oncotarget. 2017 Jan 31;8(5):8867-8876. doi: 10.18632/oncotarget.12817. Review.

17.
18.

Expression of Pim-3 in colorectal cancer and its relationship with prognosis.

Zhou Z, Zhang R, Wang R, Zhang Y, Xu L, Chen J, Zhang J, Huang Z, Chen M, Pan Z.

Tumour Biol. 2016 Jul;37(7):9151-6. doi: 10.1007/s13277-016-4806-7. Epub 2016 Jan 14.

PMID:
26768612
19.

[Radiofrequency ablation and multidisciplinary treatment for liver cancer].

Chen M.

Zhonghua Yi Xue Za Zhi. 2015 Jul 21;95(27):2174-7. Chinese. No abstract available.

PMID:
26710906
20.

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.

Zhou D, Zhang Y, Xu L, Zhou Z, Huang J, Chen M.

Sci Rep. 2015 Oct 21;5:15263. doi: 10.1038/srep15263.

Supplemental Content

Loading ...
Support Center